Cassaday & Co Wealth Management LLC Acquires Shares of 1,419 The Clorox Company (NYSE:CLX)

Cassaday & Co Wealth Management LLC bought a new position in The Clorox Company (NYSE:CLX) in the 3rd quarter, according to its most recent disclosure with the SEC. The firm bought 1,419 shares of the company’s stock, valued at approximately $231,000.

A number of other large investors have also recently modified their holdings of CLX. Mizuho Securities USA LLC lifted its position in Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after buying an additional 4,490,421 shares during the period. Nuance Investments LLC boosted its stake in Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after acquiring an additional 960,094 shares in the last quarter. Van ECK Associates Corp grew its holdings in Clorox by 2.2% in the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after purchasing an additional 31,510 shares during the period. Bank of New York Mellon Corp increased its stake in shares of Clorox by 14.4% during the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock valued at $131,200,000 after purchasing an additional 120,716 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Clorox by 11.9% during the second quarter. Dimensional Fund Advisors LP now owns 802,237 shares of the company’s stock valued at $109,483,000 after purchasing an additional 85,529 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of Clorox stock opened at $169.14 on Tuesday. The stock’s fifty day moving average is $162.53 and its 200 day moving average is $147.73. The Clorox Company has a one year low of $127.60 and a one year high of $169.21. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The stock has a market cap of $20.94 billion, a P/E ratio of 58.93, a P/E/G ratio of 3.10 and a beta of 0.41.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.49 earnings per share. Sell-side analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.89%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is 170.03%.

Insider Buying and Selling

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.57% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on CLX shares. Citigroup lifted their price objective on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and lifted their target price for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Barclays increased their price target on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. Finally, Evercore ISI decreased their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.